Artículo de revista
Heterocyclic curcumin derivatives of pharmacological interest: Recent progress
Fecha
2015Registro en:
Current Topics in Medicinal Chemistry, Volumen 15, Issue 17, 2018, Pages 1663-1672
18734294
15680266
10.2174/1568026615666150427111837
Autor
Martínez Cifuentes, Maximiliano
Weiss López, Boris
Santos, Leonardo S.
Araya Maturana, Ramiro
Institución
Resumen
© 2015, Bentham Science Publishers. Curcumin, a natural yellow polyphenol, is isolated from the herb Curcuma longa L. (turmeric), a member of the ginger family. It has been extensively studied due to their multiple pharmacological properties. Nevertheless, curcumin has disadvantages such as poor water solubility, poor bioavailability and rapid metabolism, which has prompted the search for analogues that overcome these shortcomings while maintaining or improving their good pharmacological properties. Among the main curcumin analogues that have been developed, the heterocyclic curcuminoids show a high interest. In this review, we describe recent progress in the synthesis and pharmacological properties of new heterocyclic curcumin derivatives. The most recent developments in anti-cancer, anti-Alzheimer, anti-bacterial and anti-oxidants heterocyclic curcumin derivatives are covered.